Perform Another (Advanced) Search

1.  Study Posting (3684) Trial #153269, Eczema (Atopic Dermatitis), Edina, MN
...Study Posting (3684) Trial #153269, Eczema (Atopic Dermatitis), Edina, MN Trial Information Chronic Hand Eczema Study If you have severe chronic hand eczema, then you may eligible to participate in a new research study. Main Requirements for ...
View Page

2.  Study Posting (1127) Trial #153230, Eczema (Atopic Dermatitis), Longmont, CO
...Study Posting (1127) Trial #153230, Eczema (Atopic Dermatitis), Longmont, CO Trial Information CHRONIC HAND ECZEMA If you have had chronic hand eczema for at least 6 months and failed treatment with topical corticosteroids you may be ...
View Page

3.  Study Posting (455) Trial #154297, Eczema (Atopic Dermatitis), Wheat Ridge, CO
...Trial #154297, Eczema (Atopic Dermatitis), Wheat Ridge, CO Trial Information Research Study for Severe Chronic Hand Eczema We are seeking volunteers 18 to 75 years old and in general good health who have been diagnosed with severe chronic hand eczema for at least the last 6 months. This condition must be resistant to standard ...
View Page

4.  Study Posting (4519) Trial #134052, Breast Cancer, Teresina, Brazil
...4519) Trial #134052, Breast Cancer, Teresina, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

5.  Study Posting (4519) Trial #134054, Breast Cancer, Taguatinga, Brazil
...4519) Trial #134054, Breast Cancer, Taguatinga, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

6.  Study Posting (4519) Trial #134036, Breast Cancer, Sorocaba, Brazil
...4519) Trial #134036, Breast Cancer, Sorocaba, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

7.  Study Posting (4519) Trial #134041, Breast Cancer, Santos, Brazil
...4519) Trial #134041, Breast Cancer, Santos, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

8.  Study Posting (4519) Trial #134038, Breast Cancer, Salvador, Brazil
...4519) Trial #134038, Breast Cancer, Salvador, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

9.  Study Posting (4519) Trial #134053, Breast Cancer, Petrópolis, Brazil
...4519) Trial #134053, Breast Cancer, Petrópolis, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

10.  Study Posting (4519) Trial #134049, Breast Cancer, Niteroi, Brazil
...4519) Trial #134049, Breast Cancer, Niteroi, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

11.  Study Posting (4519) Trial #134050, Breast Cancer, Natal, Brazil
...4519) Trial #134050, Breast Cancer, Natal, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

12.  Study Posting (4519) Trial #159482, Breast Cancer, Maceió, Brazil
...4519) Trial #159482, Breast Cancer, Maceió, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

13.  Study Posting (4519) Trial #134051, Breast Cancer, Lajeado, Brazil
...4519) Trial #134051, Breast Cancer, Lajeado, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

14.  Study Posting (4519) Trial #134040, Breast Cancer, Jaú, Brazil
...4519) Trial #134040, Breast Cancer, Jaú, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

15.  Study Posting (4519) Trial #134048, Breast Cancer, Itajaí, Brazil
...4519) Trial #134048, Breast Cancer, Itajaí, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

16.  Study Posting (4519) Trial #134046, Breast Cancer, Ijuí, Brazil
...4519) Trial #134046, Breast Cancer, Ijuí, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

17.  Study Posting (4519) Trial #134047, Breast Cancer, Goiania, Brazil
...4519) Trial #134047, Breast Cancer, Goiania, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

18.  Study Posting (4519) Trial #134043, Breast Cancer, Fortaleza, Brazil
...4519) Trial #134043, Breast Cancer, Fortaleza, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

19.  Study Posting (4519) Trial #134044, Breast Cancer, Florianopolis, Brazil
...4519) Trial #134044, Breast Cancer, Florianopolis, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page

20.  Study Posting (4519) Trial #134031, Breast Cancer, Campinas, Brazil
...4519) Trial #134031, Breast Cancer, Campinas, Brazil Trial Information A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Status: Recruiting Protocol Number: ML21419 Sponsor ...
...open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal ...
View Page